Aim

To explore two main areas within breast cancer research. The first area is the identification of genetic determinants of non-BRCA1/2-linked familial breast cancer, with the second area being the search for novel biomarkers for diagnosis, prognosis, and prediction of therapy response of breast cancer. The ultimate goal of the program is to identify novel biomarkers for breast cancer that contribute to the improvement of patient survival in Qatar and the MENA region.

Scientific Coordinators

Dr. Nehad Alajez

Translational Oncology Research Center

Investigators

Dr. Julie Decock

Translational Oncology Research Center

Dr. Fares Al Ejeh

Translational Oncology Research Center

Dr. Mariam Al-Muftah

Translational Oncology Research Center

Dr. Khalid Ouararhni

HBKU Core Facilities

Dr. Abdelilah Arredouani

Diabetes Research Center(DRC)

Dr. Omar El Agnaf

Neurological Research Center (NDRC)

Dr. Houari Abdesselem

HBKU Core Facilities

Collaborators

Dr. Salahddin Gehani

Hamad Medical Corporation (HMC)

Dr. Salha Bujassoum

Hamad Medical Corporation (HMC)

Hikmat Abdel-Razaq

King Hussein Cancer Center (KHCC), Jordan

Dr. Omar Albagha

College of Health and Life Sciences (CHLS), HBKU